Welcome to LookChem.com Sign In|Join Free
  • or
Benzoyl chloride, 2-chloro-3-fluoro- (8CI,9CI) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

21900-57-2

Post Buying Request

21900-57-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

21900-57-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 21900-57-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,1,9,0 and 0 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 21900-57:
(7*2)+(6*1)+(5*9)+(4*0)+(3*0)+(2*5)+(1*7)=82
82 % 10 = 2
So 21900-57-2 is a valid CAS Registry Number.

21900-57-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-chloro-3-fluorobenzoyl chloride

1.2 Other means of identification

Product number -
Other names 2-chloro-3-fluorobenzoic acid chloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:21900-57-2 SDS

21900-57-2Relevant academic research and scientific papers

METHOD OF TREATMENT

-

Page/Page column 13, (2009/04/25)

This invention relates to the use of a sulfonamide substituted diphenyl urea compound to treat cystic fibrosis, or the symptoms associated with cystic fibrosis.

METHOD OF TREATMENT

-

, (2008/06/13)

This invention relates to the use of sulfonamide substituted diphenyl urea compounds to treat endometriosis.

IL-8 RECEPTOR ANTAGONISTS

-

Page/Page column 18-19, (2008/06/13)

This invention relates to novel compounds and compositions thereof, useful in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8).

IL-8 RECEPTOR ANTAGONISTS

-

Page/Page column 12-13, (2010/11/08)

This invention relates to novel compounds of Formula (I) to (VII), and compositions thereof, useful in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8).

IL-8 RECEPTOR ANTAGONISTS

-

Page 12-13, (2008/06/13)

This invention relates to novel compounds of Formula (I) to (VII), and compositions thereof, useful in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 21900-57-2